These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32725366)

  • 1. Factors affecting patient choice for continued observation versus intervention for pelvic organ prolapse.
    Mbaye M; Autumn Edenfield L; Woll A; Swift SE
    Int Urogynecol J; 2021 Feb; 32(2):273-278. PubMed ID: 32725366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse.
    Gilchrist AS; Campbell W; Steele H; Brazell H; Foote J; Swift S
    Neurourol Urodyn; 2013 Apr; 32(4):383-6. PubMed ID: 22907839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolapse surgery versus vaginal pessary in women with symptomatic pelvic organ prolapse: which factors influence the choice of treatment?
    Bodner-Adler B; Bodner K; Stinglmeier A; Kimberger O; Halpern K; Koelbl H; Umek W
    Arch Gynecol Obstet; 2019 Mar; 299(3):773-777. PubMed ID: 30656443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital Hiatus Size as a Predictor of Progression of Pelvic Organ Prolapse.
    Woll A; Mbaye M; Edenfield A; Swift S
    Female Pelvic Med Reconstr Surg; 2021 Jun; 27(6):e555-e558. PubMed ID: 33534270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we predict continued pessary use as primary treatment in women with symptomatic pelvic organ prolapse (POP)? A prospective cohort study.
    Thys S; Hakvoort R; Milani A; Roovers JP; Vollebregt A
    Int Urogynecol J; 2021 Aug; 32(8):2159-2167. PubMed ID: 34002267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
    Manonai J; Sarit-Apirak S; Udomsubpayakul U
    Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.
    Sung VW; Wohlrab KJ; Madsen A; Raker C
    Am J Obstet Gynecol; 2016 Nov; 215(5):659.e1-659.e7. PubMed ID: 27319365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in sexual function after treatment for prolapse are related to the improvement in body image perception.
    Lowenstein L; Gamble T; Sanses TV; van Raalte H; Carberry C; Jakus S; Pham T; Nguyen A; Hoskey K; Kenton K;
    J Sex Med; 2010 Feb; 7(2 Pt 2):1023-8. PubMed ID: 19912488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery.
    Coolen AWM; Troost S; Mol BWJ; Roovers JPWR; Bongers MY
    Int Urogynecol J; 2018 Jan; 29(1):99-107. PubMed ID: 28600758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Dislodgment of Vaginal Pessaries in Women With Pelvic Organ Prolapse: A Cohort Study.
    Coelho SCA; Giraldo PC; de Castro EB; Brito LGO; Juliato CRT
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e247-e251. PubMed ID: 32487886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient characteristics associated with treatment choice for pelvic organ prolapse and urinary incontinence.
    Sullivan SA; Davidson ER; Bretschneider CE; Liberty AL; Geller EJ
    Int Urogynecol J; 2016 May; 27(5):811-6. PubMed ID: 26642799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
    Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
    Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
    Ding J; Song XC; Deng M; Zhu L
    Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
    Ramsay S; Tu le M; Tannenbaum C
    Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
    Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
    Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
    Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
    Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
    Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
    Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.
    Shayo BC; Masenga GG; Rasch V
    Int Urogynecol J; 2019 Aug; 30(8):1313-1321. PubMed ID: 30121703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].
    Yang JF; Han JS; Zhu FL; Wang YT; Yao Y; Qiao J
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):487-91. PubMed ID: 23141156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.